Patent details

EP2771326 Title: SYNTHESIS OF TRIAZOLOPYRIMIDINE COMPOUNDS

Basic Information

Publication number:
EP2771326
PCT Application Number:
EP2012071252
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP127839264
PCT Publication Number:
WO2013060837
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
SYNTHESIS OF TRIAZOLOPYRIMIDINE COMPOUNDS
French Title of Invention:
SYNTHÈSE DE COMPOSÉS DE TYPE TRIAZOLOPYRIMIDINE
German Title of Invention:
SYNTHESE VON TRIAZOLPYRIMIDIN-VERBINDUNGEN
SPC Number:

Dates

Filing date:
26/10/2012
Grant date:
20/12/2017
EP Publication Date:
03/09/2014
PCT Publication Date:
02/05/2013
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
20/12/2017
EP B1 Publication Date:
20/12/2017
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
26/10/2018
Expiration date:
26/10/2032
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
13/12/2017
 
 

Name:
LEK Pharmaceuticals d.d.
Address:
Verovskova 57, 1526 Ljubljana, Slovenia (SI)

Inventor

1

Name:
STERK, Damjan
Address:
Slovenia (SI)

2

Name:
ZUPANCIC, Borut
Address:
Slovenia (SI)

3

Name:
MARAS, Nenad
Address:
Slovenia (SI)

Priority

1

Priority Number:
11186817
Priority Date:
27/10/2011
Priority Country:
European Patent Office (EPO) (EP)

2

Priority Number:
11195608
Priority Date:
23/12/2011
Priority Country:
European Patent Office (EPO) (EP)

Classification

IPC classification:
A61K 31/519; C07D 239/46; C07D 239/56; C07D 405/12; C07D 487/04;

Publication

European Patent Bulletin

Issue number:
201751
Publication date:
20/12/2017
Description:
Grant (B1)

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages
28/02/2019 Outgoing Correspondence 1